Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage
- 1 August 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 314 (2) , 738-744
- https://doi.org/10.1124/jpet.105.086553
Abstract
Angiopoietins (Angs) are endothelium-selective ligands that exert most of their actions through the Tie-2 receptor. It is widely accepted that Ang-1 promotes the structural integrity of blood vessels and exhibits anti-inflammatory properties. In contrast, the role of Ang-2 remains less clear because it has been shown to behave as a Tie-2 agonist or antagonist under different experimental conditions. To define the role of Ang-2 in acute inflammation, we studied the effects of recombinant Ang-2 administration in vivo. We show herein that Ang-2, but not Ang-1, induces edema formation in the mouse paw in a dose-dependent manner; the edema seems to be fast-peaking (maximum at 30 min) and resolves within 4 h. The effect of Ang-2 is blocked by the coadministration with a soluble form of the Tie-2 receptor or Ang-1. NO and prostaglandin E2 levels in mouse paw following the injection of Ang-2 remained unaltered, suggesting that the action of Ang-2 does not involve these mediators. In addition, Ang-2 exerted a weak stimulatory effect on leukocyte migration in the mouse paw. Similarly, Ang-2 injected into the mouse air pouch produced only a modest effect on cell extravasation that peaked at 30 min. However, when cell migration was elicited using zymosan, Ang-2 significantly inhibited leukocyte migration. We conclude that Ang-2 by itself stimulates the extravasation of cell-poor fluid, but in the presence of ongoing inflammation it reduces cellular infiltration in tissues.This publication has 34 references indexed in Scilit:
- Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responsesBlood, 2005
- Role of protein kinase Cζ in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1Blood, 2004
- HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endotheliumJournal of Applied Physiology, 2004
- VEGF signalling: integration and multi-tasking in endothelial cell biologyBiochemical Society Transactions, 2003
- Opposing effect of angiopoietin‐1 on VEGF‐mediated disruption of endothelial cell–cell interactions requires activation of PKCβJournal of Cellular Physiology, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Angiopoietin‐1 inhibits endothelial permeability, neutrophil adherence and IL‐8 productionBritish Journal of Pharmacology, 2003
- Points of control in inflammationNature, 2002
- Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin PathwayJournal of Biological Chemistry, 2000
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999